Primer, probe and detection method for detecting human adenovirus based on fluorescent quantitative PCR (Polymerase Chain Reaction) technology

Through the detection method based on fluorescence quantitative PCR technology, primers and probes are designed using conserved regions of human adenoviruses, the problem of low sensitivity for detecting various genotypes of human adenoviruses in the prior art is solved, and efficient and quantitative detection results are achieved .

CN119061197AInactive Publication Date: 2024-12-03QINGDAO GUOKE QUALITY DETECTION CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410609985.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-05-16
Publication Date
2024-12-03
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the prior art, human adenovirus detection methods are mainly aimed at a single genotype, lack general methods and have low sensitivity, and cannot effectively detect human adenoviruses of multiple genotypes, and most of the methods are qualitative rather than quantitative.

Method used

A detection method based on fluorescence quantitative PCR technology was designed. By comparing the hexon gene sequences of human adenoviruses of different genotypes, conserved regions were obtained, appropriate primers and probes were designed, and plasmid standards were constructed in combination with pUC-GW-Kan vector. , perform fluorescence quantitative PCR reaction, screen the optimal primers and probes, and establish a general detection method.

Benefits of technology

It realizes efficient, stable and sensitive quantitative detection of human adenoviruses of various genotypes, with a detection limit of up to 25copies/reaction, with good repeatability and precision, can accurately detect quantitatively, and has good specificity, and is not suitable for non-human glands. The virus reacts.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061197A_ABST
    Figure CN119061197A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of human adenovirus detection, in particular to a primer, a probe and a detection method for detecting human adenovirus based on a fluorescent quantitative PCR (Polymerase Chain Reaction) technology, provides a primer and a probe for universal detection of human adenovirus (HAdV), and successfully establishes a universal human adenovirus detection method based on the fluorescent quantitative PCR technology. The sensitivity of the method is higher, and the detection limit can reach 25 copies / reaction; and accurate quantification can be realized. In addition, the method has good repeatability and precision; the method is high in detection efficiency and good in specificity, universal detection of various genotypes of human adenoviruses can be realized, and the method has no reaction to other non-human adenoviruses.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of human adenovirus detection, and in particular to primers, probes and a detection method for detecting human adenovirus based on fluorescent quantitative PCR technology. Background Art

[0002] Human adenovirus (HAdV) is a DNA virus belonging to the family Adenoviridae, without an envelope structure. Their genome size is about 36 kb and encodes about 40 proteins, including Penton bases, Hexon and Fiber proteins (Davison AJ et al., 2003). HAdV can infect various tissues and organs, causing a range of diseases of varying severity, such as sore throat, rhinitis, fever, pneumonia and bronchitis (Radke JR et al., 2018). Although anyone can be affected by HAdV, people with weakened immune systems, cardiovascular diseases and young children are at higher risk of severe illness (Sawires R et al., 2023). So far, at least 113 HAdV genotypes have been identified and divided into seven species (AG) from A to G based on their physical, chemical and biological properties (Greber UF et al., 2020). Different genotypes may lead to different clinical features. HAdV F includes serotypes 40 and 41, which are associated with gastroenteritis; genotypes 19 and 37 can cause eye diseases; genotypes 3, 4, 7, 14, 21, and 55 are known to cause severe infections and are associated with global outbreaks (Liu MC et al., 2023)(Salama M et al., 2016)(Philo SE et al., 2018). In recent years, new HAdV genotypes with new pathogenicity and epidemiological characteristics have emerged, posing new threats and challenges to public health (Mennechet FJD, 2019). With the vigorous development of the biopharmaceutical industry, the detection of exogenous and exogenous viral factors including human adenovirus has become a mandatory inspection item for all kinds of products. Countries have issued relevant regulations and documents in order to control such contamination risks: the third biological general rules of the Chinese Pharmacopoeia (2020 edition) "Preparation and Quality Control of Animal Cell Matrices for Production and Inspection of Biological Products" and the "Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs)" issued by the FDA in 2020 clearly point out in the cell matrix inspection section that it is necessary to check whether the cell matrix of human origin contains adenovirus (HAdV).

[0003] As an emerging molecular detection technology, fluorescent quantitative PCR (qPCR) technology has been increasingly widely used in biological product quality control due to its advantages of high sensitivity and high accuracy. The current human adenovirus detection methods based on qPCR technology are mainly detection methods for a single genotype of adenovirus. There are few universal methods covering all genotypes of human adenovirus detection and the sensitivity is low (usually only up to 500 copies / reaction), and most of the current methods are qualitative methods rather than quantitative methods.

[0004] Therefore, it is necessary to invent a universal method that can simultaneously efficiently, stably, sensitively and quantitatively detect human adenovirus of various genotypes. Summary of the invention

[0005] In view of the deficiencies of the prior art, the present invention designs a primer, a probe and a detection method for detecting human adenovirus based on fluorescent quantitative PCR technology, and the device is intended to solve the problems of the prior art.

[0006] To achieve the above object, the present invention provides the following technical solutions:

[0007] A primer and a probe for detecting human adenovirus based on fluorescent quantitative PCR technology, the preparation process includes the following steps:

[0008] 1) Download 25 genotypes of human adenovirus gene sequences from the NCBI (National Center for Biotechnology Information) database;

[0009] 2) using snapgene software to align the 25 genotypes of human adenovirus hexon gene sequences in step 1) to obtain the common sequence of human adenovirus hexon genes of different genotypes, and using the aligned human adenovirus conserved sequence as the detection target;

[0010] 3) Design appropriate primer and probe sequences in the conserved region;

[0011] 4) Connect the conserved region of human adenovirus to the pUC-GW-Kan vector to construct a positive plasmid standard, and synthesize the plasmid standard;

[0012] 5) Prepare the plasmid standard into a 1×10^8 copies / μL storage solution, and dilute the storage solution in a 10-fold gradient using EASY Dilution (Takara, 9160), a special diluent for quantitative PCR;

[0013] 6) Prepare qPCR reaction system;

[0014] 7) Testing the qPCR reaction system using a fluorescent quantitative PCR instrument;

[0015] 8) By observing the specific performance of the amplification products of each pair of primers, the optimal primer pair and its corresponding probe are screened.

[0016] As a preferred scheme of the present invention, the concentrations of the storage solution after dilution in step 5) are: 1×10^7copies / μL, 1×10^6copies / μL, 1×10^5copies / μL, 1×10^4copies / μL, 1×10^3copies / μL, 1×10^2copies / μL, 10copies / μL, 1copy / μL.

[0017] As a preferred embodiment of the present invention, the qPCR reaction system in step 6) includes the following components: 12.5 μL TB Green Premix Ex Taq (2X), 200 nmol upstream primer (μM), 200 nmol downstream primer (μM), 0.5 μL ROX Reference Dye II (50X), 5 μL reaction template (positive controls of various concentrations and no-template control NTC), and finally the volume is made up to 25 μL with RNase / DNase-free water.

[0018] As a preferred solution of the present invention, the program parameters of the fluorescence quantitative PCR instrument in step 7) are shown in the following table:

[0019]

[0020] A method for detecting human adenovirus based on fluorescent quantitative PCR technology, comprising the following steps:

[0021] 9) Use Probe qPCR Mix, with UNG (Takara, RR392A) probe amplification reagent, and use the standard plasmid with a concentration of 1×10^5 copies / μL as the amplification template to test different primer concentration systems;

[0022] 10) According to the amplification curve and Ct value displayed by the fluorescence quantitative PCR instrument after the reaction of different primer concentration systems is completed, the reaction system with a slightly obvious advantage is the optimal primer concentration;

[0023] 11) Dilute the plasmid standard stock solution synthesized in step 4 in a 10-fold gradient using EASY Dilution (Takara, 9160), a special diluent for quantitative PCR;

[0024] 12) The optimal primer and its corresponding probe were prepared into a 400 nM reaction system for detection, and each concentration standard was tested in triplicate wells;

[0025] 13) Preliminarily determine the detection range and linear range of the method based on the Ct values ​​of the standard samples at various concentrations after the reaction is completed.

[0026] As a preferred solution of the present invention, the different primer concentrations described in step 9) are: 100nM, 200nM, 300nM, 400nM, 500nM.

[0027] As a preferred solution of the present invention, the concentrations of the diluted storage solution in step 11) are: 1×10^7copies / μL, 1×10^6copies / μL, 1×10^5copies / μL, 1×10^4copies / μL, 1×10^3copies / μL, 1×10^2copies / μL, 10copies / μL, 1copy / μL.

[0028] As a preferred solution of the present invention, the parameters of the fluorescence quantitative PCR instrument described in step 10) are set as follows:

[0029]

[0030] Compared with the prior art, the present invention has the following beneficial effects:

[0031] 1. The present invention obtains the conserved regions of various human adenovirus hexon genes by simultaneously comparing the hexon gene sequences of human adenoviruses of different genotypes, and designs two pairs of primer probes in the conserved regions. Then, the most suitable primer probes and the optimal reaction system are screened through primer screening, system optimization and other tests, and the method is established. Then, the detection limit, detection range and accurate quantitative range of the established method are determined. The method is further proved to have good repeatability and precision through experiments. Finally, the standard products / reference products represented by different human adenoviruses (HAdV) A to F and the virus reference products of non-human adenovirus are detected, thereby further proving the practical applicability of the established method.

[0032] 2. The present invention provides primers and probes for universal detection of human adenovirus (HAdV), and successfully establishes a universal human adenovirus detection method based on fluorescent quantitative PCR technology. Compared with the existing technology, the method has higher sensitivity, the detection limit can reach 25 copies / reaction, and can achieve accurate quantification. In addition, the method has good repeatability and precision; the method has high detection efficiency and good specificity, can realize universal detection of human adenoviruses of various genotypes, and has no reaction to other non-human adenoviruses. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 This is a diagram showing the comparison of different human adenovirus hexon gene sequences;

[0034] Figure 2 is the primer melting curve;

[0035] Figure 3 It is the amplification curve diagram of each reaction system;

[0036] Figure 4 This is the standard curve diagram with a concentration range of 1×10^7 copies / μL to 10 copies / μL;

[0037] Figure 5 Amplification curve of test samples. DETAILED DESCRIPTION

[0038] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0039] Example:

[0040] The present invention provides a technical solution:

[0041] The hexon gene is responsible for encoding the polypeptide II protein of the viral capsid. Although the genomic nucleic acid sequences of different genotypes of human adenovirus (HAdV) are significantly different, there are conserved regions in the hexon gene among different genotypes of adenovirus. Based on this, we used snapgene software to align the nucleic acid sequences of the hexon genes of 25 genotypes of human adenovirus (HAdV) covering seven species from A to G, and used the conserved regions obtained as universal detection targets for human adenovirus. Appropriate primer probe sequences were designed in the conserved regions, in order to achieve efficient detection of human adenovirus (HAdV) covering different species from A to G through only one tube reaction. The hexon gene sequences of the 25 genotypes of human adenovirus used were downloaded from the NCBI (National Center for Biotechnology Information) database. The specific information is shown in Table 1.

[0042] The hexon gene sequences of 25 genotypes of human adenovirus were compared. Figure 1, the yellow highlighted sequence is the common sequence of the hexon gene of human adenovirus of different genotypes. The conserved sequence obtained by comparison is used as the detection target, and suitable primer probes are designed in this region and commissioned to be synthesized by a synthesis company. The present invention initially selects 2 pairs of primer probe pairs for synthesis, and then selects primer probe pairs with better performance in various aspects as the final detection sequence through experimental testing. In addition, the conserved region is connected to the pUC-GW-Kan vector to construct a positive plasmid standard. The successfully constructed positive plasmid standard contains the fragments to be amplified by both pairs of primers. The specific information of the 2 pairs of primer probe pairs and the nucleic acid sequence of the conserved region are shown in Table 2. Next, the selected 2 pairs of primer probe pairs need to be screened through experiments and the primer probe pair with better performance is determined as the primer probe for detection.

[0043] Table 1: Hexon gene information of 25 genotypes of human adenovirus

[0044]

[0045]

[0046] Table 2: Primer probe sequences

[0047]

[0048]

[0049]

[0050] Furthermore, the synthesized plasmid standard was prepared into a 1×10^8copies / μL storage solution, and the storage solution was diluted in a 10-fold gradient to 1×10^7copies / μL, 1×10^6copies / μL, 1×10^5copies / μL, 1×10^4copies / μL, 1×10^3copies / μL, 1×10^2copies / μL, 10copies / μL, and 1copy / μL concentrations using a quantitative PCR-specific diluent EASY Dilution (Takara, 9160). Two pairs of primers were used to experiment with the diluted series of positive controls, with three replicate wells set for each concentration. The qPCR reaction system was prepared as follows: a total of 25μL, including 12.5μL TB Green Premix Ex Taq (2X), 200nmol upstream primer (μM), 200nmol downstream primer (μM), 0.5μL ROX Reference Dye II (50X), 5 μL reaction template (positive control of each concentration and no template control NTC), and finally use RNase / DNase-free water to make up the volume to 25 μL. After the qPCR reaction system is prepared, the reaction is carried out according to the reagent recommended reaction program (Table 3). After the reaction is completed, the specific performance of the amplification products of each pair of primers is observed to screen a more suitable primer pair.

[0051] After the two pairs of primer reaction systems are completed, their respective melting curves are as follows Figure 2 As shown, primer pair 1 produces a weaker nonspecific amplification peak in the reaction of low-concentration plasmid standards, while primer pair 2 presents a single specific amplification peak from high concentration to low concentration. It can be considered that primer pair 2 has better specificity than primer pair 1 when amplifying standard plasmids of various concentrations, and therefore primer pair 2 and its corresponding probe are selected as the primer probe for detection.

[0052] Table 3: Primer screening reaction procedure

[0053]

[0054] Furthermore, the probe detection system is optimized:

[0055] Probe qPCR Mix, with UNG (Takara, RR392A) probe amplification reagent, with 1×10^5 copies / μL concentration of standard plasmid as amplification template, different primer concentration systems were tested, the primer pair used the primer pair 2 and its corresponding probe screened above, and a total of 5 primer concentration reaction systems (panHAdV-F2: panHAdV-R2: panHAdV-P2 = 1: 1: 0.5) were tested in the experiment, and the reaction was carried out according to the recommended reaction procedure of the probe method reagent (Table 5). According to the amplification curves and Ct values ​​presented by the fluorescence quantitative PCR instrument after the reaction of different systems was completed, the optimal primer concentration was analyzed and determined.

[0056] Amplification curves of each reaction system Figure 3 As shown in Table 6, the tested reaction systems all showed typical amplification curves with good trends, and the negative controls of each system had no amplification curves; the Ct values ​​corresponding to each reaction system are summarized in Table 6. When the primer concentration was 400nM, the reaction system results showed a slightly obvious advantage, so the reaction system corresponding to the 400nM primer concentration was determined to be the optimal system for the test. Next, the 400nM concentration primer pair 2 corresponding reaction system was used to continue the test of the detection range, the establishment of the quantitative standard curve, and the determination of the detection limit.

[0057] Table 4: Preparation of primer systems at different concentrations

[0058]

[0059] Table 5: System optimization reaction program

[0060]

[0061] Table 6: Summary of Ct values ​​of each reaction system

[0062]

[0063] Then, the detection range was tested, the standard curve was established and the detection limit was determined:

[0064] The synthesized plasmid standard stock solution was diluted in a 10-fold gradient to 1×10^7 copies / μL, 1×10^6 copies / μL, 1×10^5 copies / μL, 1×10^4 copies / μL, 1×10^3 copies / μL, 1×10^2 copies / μL, 10 copies / μL, and 1 copy / μL concentrations using the quantitative PCR special diluent EASY Dilution (Takara, 9160). Probe qPCR Mix, with UNG (Takara, RR392A) amplification reagent, the primer pair 2 and its probe determined above were screened and determined, and a 400 nM reaction system was prepared for detection. Each concentration of the standard was tested in triplicate wells. Finally, the detection range and linear range of the method were preliminarily determined based on the Ct values ​​of each concentration of the standard after the reaction was completed.

[0065] The Ct values ​​of the standard samples at concentrations of 1×10^7copies / μL to 1copies / μL are summarized in Table 7. The results show that the standard samples at concentrations of 1×10^7copies / μL to 10copies / μL were detected in all three replicate wells, the standard samples at concentrations of 1copies / μL were detected in only two wells, and none of the NTC wells were detected. It can be preliminarily determined that this method can accurately detect human adenovirus (HAdV) within the concentration range of 1×10^7copies / μL to 10copies / μL. The linearity of the standard samples within the concentration range of 1×10^7copies / μL to 10copies / μL was good, such as Figure 4 , linear correlation coefficient R 2 The amplification efficiency was good, and the amplification efficiency Eff% could reach 97.816%, so the standard curve range for accurate quantification was 1×10^7 copies / μL~10 copies / μL.

[0066] In addition, through the statistics of the detection range data, it was found that the lowest concentration of the standard detected in all three replicate wells was 10 copies / μL (50 copies / reaction). Based on this result, it was necessary to set standards of different concentrations around 10 copies / μL (50 copies / reaction) to test the detection limit of the established detection method.

[0067] Table 7: Summary of Ct values ​​of standard samples at different concentrations

[0068]

[0069]

[0070] Furthermore, the detection limit experiment:

[0071] As shown in the test results of the detection range, the lowest concentration of the standard detected in all three replicate wells using the established method is 10 copies / μL (50 copies / reaction). Based on this result, the standard was diluted to 1 copy / μL, 5 copies / μL, 10 copies / μL, 15 copies / μL, and 20 copies / μL, and the established method was used for detection. Ten replicate wells were tested for each concentration. After the test was completed, the results were summarized and the detection rate of each concentration was calculated. The lowest concentration detected in all 10 replicate wells is the detection limit of the established method.

[0072] The test results of the standard samples at various concentrations are summarized in Table 8, where 2 out of 10 wells with 5 copies / reaction (1 copy / μL reaction well) were not detected, with a detection rate of 80%; all 10 wells with 25 copies / reaction (5 copies / μL) reaction wells and standards of higher concentrations were detected, with a detection rate of 100%, so the detection limit of the method is 25 copies / reaction.

[0073] Table 8: Summary of detection limit experimental results

[0074]

[0075]

[0076]

[0077] Finally, method repeatability and precision:

[0078] In order to further verify the reliability of the method, the repeatability and precision of the method were verified accordingly during the experiment of the present invention. Three independent linear repeat experiments were performed at different times. The standard stock solution was diluted to a linear range of 1×10^7 copies / μL to 1×10 copies / μL using EASY Dilution (Takara, 9160), a special diluent for quantitative PCR, in a 10-fold gradient. The established method was used for detection. Three replicate wells were tested for each concentration of the standard. The linear correlation coefficient R 2 The repeatability and precision of the method were comprehensively evaluated by measuring the amplification efficiency of the method and the variation of the Ct values ​​of the standard samples at different concentrations in different experiments.

[0079] The results show that the linearity of the three linear experiments is good, R 2The amplification efficiency of the method was good, and the amplification efficiency of the three experiments was in the range of 90% to 110%; and the coefficient of variation (CV%) of the Ct value of each concentration of the standard in different independent experiments was no more than 5%. The overall explanation is that the repeatability and precision of the established method are good, and the method has considerable reliability.

[0080] Table 9: Summary of precision experimental data

[0081]

[0082]

[0083] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A primer and probe for detecting human adenovirus based on fluorescent quantitative PCR technology, characterized in that: The preparation process includes the following steps: 1) Download 25 genotypes of human adenovirus gene sequences from the NCBI (National Center for Biotechnology Information) database; 2) using snapgene software to align the 25 genotypes of human adenovirus hexon gene sequences in step 1) to obtain the common sequence of human adenovirus hexon genes of different genotypes, and using the aligned human adenovirus conserved sequence as the detection target; 3) Design appropriate primer and probe sequences in the conserved region; 4) Connect the conserved region of human adenovirus to the pUC-GW-Kan vector to construct a positive plasmid standard, and synthesize the plasmid standard; 5) Prepare the plasmid standard into a 1×10^8 copies / μL storage solution, and dilute the storage solution in a 10-fold gradient using EASY Dilution (Takara, 9160), a special diluent for quantitative PCR; 6) Prepare qPCR reaction system; 7) Testing the qPCR reaction system using a fluorescent quantitative PCR instrument; 8) By observing the specific performance of the amplification products of each pair of primers, the optimal primer pair and its corresponding probe are screened.

2. The primers and probes for detecting human adenovirus based on fluorescent quantitative PCR technology according to claim 1, characterized in that: Step 5) The concentrations of the diluted storage solution are: 1×10^7copies / μL, 1×10^6copies / μL, 1×10^5copies / μL, 1×10^4copies / μL, 1×10^3copies / μL, 1×10^2copies / μL, 10copies / μL, 1copy / μL.

3. The primers and probes for detecting human adenovirus based on fluorescent quantitative PCR technology according to claim 1, characterized in that: In step 6), the qPCR reaction system includes the following components: 12.5 μL TB Green Premix Ex Taq (2X), 200 nmol upstream primer (μM), 200 nmol downstream primer (μM), 0.5 μL ROX Reference Dye II (50X), 5 μL reaction template (positive control of each concentration and no template control NTC), and finally the volume is made up to 25 μL with RNase / DNase-free water.

4. The primer for detecting human adenovirus based on fluorescent quantitative PCR technology according to claim 1, characterized in that: The program parameters of the fluorescence quantitative PCR instrument in step 7) are shown in the table below:

5. A method for detecting human adenovirus based on fluorescent quantitative PCR technology, using the primers and probes for detecting human adenovirus based on fluorescent quantitative PCR technology according to any one of claims 1 to 5, characterized in that: The following steps are involved: 9) Use Probe qPCR Mix, with UNG (Takara, RR392A) probe amplification reagent, and use the standard plasmid with a concentration of 1×10^5 copies / μL as the amplification template to test different primer concentration systems; 10) According to the amplification curve and Ct value displayed by the fluorescence quantitative PCR instrument after the reaction of different primer concentration systems is completed, the reaction system with a slightly obvious advantage is the optimal primer concentration; 11) Dilute the plasmid standard stock solution synthesized in step 4 in a 10-fold gradient using EASY Dilution (Takara, 9160), a special diluent for quantitative PCR; 12) The optimal primer and its corresponding probe were prepared into a 400 nM reaction system for detection, and each concentration standard was tested in triplicate wells; 13) Preliminarily determine the detection range and linear range of the method based on the Ct values ​​of the standard samples at various concentrations after the reaction is completed.

6. A method for detecting human adenovirus based on fluorescent quantitative PCR technology according to claim 5, characterized in that: The different primer concentrations described in step 9) are: 100nM, 200nM, 300nM, 400nM, and 500nM.

7. A method for detecting human adenovirus based on fluorescent quantitative PCR technology according to claim 5, characterized in that: The concentrations of the diluted storage solution described in step 11) are: 1×10^7copies / μL, 1×10^6copies / μL, 1×10^5copies / μL, 1×10^4copies / μL, 1×10^3copies / μL, 1×10^2copies / μL, 10copies / μL, 1copy / μL.

8. A method for detecting human adenovirus based on fluorescent quantitative PCR technology according to claim 5, characterized in that: The parameters of the fluorescence quantitative PCR instrument described in step 10) are set as follows:

Citation Information

Patent Citations

  • Primer and probe for detecting and classifying adenovirus and kit and method

    CN110387439A

  • Adenovirus detection typing kit and method

    CN117106969A